Kartik Ramamoorthi
About Kartik Ramamoorthi
Kartik Ramamoorthi is the co-founder and CEO of a biotech company, known for his educational background in neuroscience from MIT and Rutgers University, and his recognition in multiple prestigious under-40 lists.
Kartik Ramamoorthi - Title and Current Roles
Kartik Ramamoorthi is a Co-founder, Chief Executive Officer, and Board Member. In these roles, he oversees major strategic decisions and company operations. His leadership is integral to business development and organizational growth. As a Board Member, he provides crucial governance input to help steer the company towards its goals.
Kartik Ramamoorthi's Educational Background
Kartik Ramamoorthi earned his Ph.D. in Molecular & Cellular Neuroscience from MIT in 2014. His doctoral research focused on advanced topics in neuroscience, preparing him for a career in biotechnology and pharmaceuticals. Prior to his Ph.D., Kartik graduated with a B.S. in Cell Biology and Neuroscience from Rutgers University in 2008. This undergraduate education provided a strong foundational knowledge in biological sciences.
Voyager Therapeutics and Kartik Ramamoorthi
Before his current roles, Kartik Ramamoorthi served on the team that launched Voyager Therapeutics. This experience involved significant contributions to the early development and strategic planning of the company. Voyager Therapeutics is known for its focus on developing gene therapies for severe neurological diseases, an area well-aligned with Kartik’s academic background.
Kartik Ramamoorthi's Awards and Recognitions
Kartik Ramamoorthi has been recognized with several awards, highlighting his contributions to the biotech industry. Some notable recognitions include San Francisco Business Times 40 Under 40 (2021), Fortune 40 Under 40 (2020), Endpoints 20 Under 40 (2020), Goldman Sachs 100 Most Intriguing Entrepreneurs (2019), and Business Insider 30 Biotech Leaders Under 40 Shaping the Future of Medicine (2017). These accolades acknowledge his influence and leadership in the field.